
FAD-GDH Blood Glucose Meter with Wild Htc Range ,
Blood Sugar Monitoring Device with Capacity for 200 results Momery
Application
Features
1.Memory with capacity for 200 results
2.Automatic strips ejections
3.0.6 ul blood sample
4.No coding
5.Virtually pain free glucose testing
6.Automatically applying blood sample
SAFE-ACCU
BLOOD GLUCOSE MONITORING SYSTE
SPECIFICATION
FAD-GDH System | |
Blood sample: | fresh capillary whole blood, venous whole blood |
Calibration sample: | venous plasma |
Test range: | 20-600mg/dL(1.1-33.3mmol/L) |
Test time: | 5s |
Blood volume: | 0.6ul |
HCT: | 30-60% |
Expiry date: | 24 months |
Memory: | 10 test results |
Battery lifetime: | above 1000 times |
Attention
Storage or transport temperature 1-30 Celsius
Please avoid direct sunlight;
Please do not bend the strips or keep strips under pressure;
Please keep the strips out of the reach of children;
Please do not use iodine for disinfection.
Sinocare Devotes To Be The Leading Diabetes Management Expert In
China And BGM Expert In The World.
Followed the value of equality, integrity, innovation and
excellence, Sinocare keeps on innovation and practice to realize
the strategic shifts from the BGMS promoter to the BGMS expert in
the world, and to be the Diabetes Management Expert of diabetes and
other chronic disease. We will provide LEARN MORE innovative and
systematic smart medical products and solutions to help diabetics
and other chronic disease patients improve their life quality.
In 2016, the acquisition of Trividia and PTS combines the two leading companies in the US with Sinocare. Together with them, Sinocare will work on improving the quality life of users, providing rapid, accurate, portable and easy to use medical device and information management system for personal and professional users.
World NO.6 largest BGMS company.
Products sold to 135 countries.
Branch offices or subsidiaries in US, India, Hong Kong and Taiwan.
More than 2,600 employees globally.
World Leading BGMS company. Products sold to 135 countries.
Sinocare has an excellent R&D team focusing on developing top-ranking Blood Glucose Monitors and other diabetes care related multi-analysis monitoring systems. Benefiting from AMM technology, Sinocare R&D team is now exploring a Prevention and Treatment Model (Monitoring-Evaluation-Intervention) to effectively manage diabetes. With goals clearly in mind, Sinocare is now transferring from “BGM Promoter of China” to“Diabetes Management Expert in China”, and “global BGM Expert”
Changsha Sinocare Inc
Sinocare is a high-tech enterprise dedicated to the development, production and sales of the rapid detection of chronic diseases in the use of bio sensing technology. Since its inception in 2002, has been adhering to the business purpose “Honor Commitment Dedicate to Healthcare", focus on promoting the development of diabetes health.
Sinocare is a high-tech enterprise dedicated to the development, production and sales of the rapid detection of chronic diseases in the use of bio sensing technology. Since its inception in 2002, has been adhering to the business purpose “Honor Commitment Dedicate to Healthcare", focus on promoting the development of diabetes health.
Sinocare as a national high-tech industrialization demonstration project, has won National Innovation Fund support, and took the lead through the ISO 13485 Quality Management System certification and the CE certification of EU. The SANNUO series blood glucose meter and a test strips, with the characteristics of the "accuracy, simple and economic", recognized by the vast number of consumers, the "Sinocare" trademark was identified as "China well known trademark by State Administration of industry and Commerce of. The products are not only popular in China, but also in the international market. In March 19, 2012, the company listed on the Shenzhen stock exchange gem, as the first Bio sensor stock in China. In 2015, the blood glucose meter in the domestic retail market share reached 51%, becoming the industry leader in blood glucose monitoring products, the same year was elected to the Forbes Asian small and medium companies top 200 list. In 2014 September,Sinocare acquired Beijing Jianheng Diabetes Hospital,to step into health service area. In January of 2016, Sinocare acquired Nipro diagnostic Inc. (now renamed as Trividia Health Inc.), the world's sixth BGM enterprise, and reached the international leading BGM corporation, In July of 2016, completed acquisition of PTS Diagnostics, expand the POCT testing business, to provide a more comprehensive solution for chronic disease prevention.